Carmona-Maurici, J.; Rosa, A.; Azcona-Granada, N.; Peña, E.; Ricart-Jané, D.; Viñas, A.; López-Tejero, M.D.; Domingo, J.C.; Miñarro, A.; Baena-Fustegueras, J.A.;
et al. Irisin as a Novel Biomarker of Subclinical Atherosclerosis in Severe Obesity. Int. J. Mol. Sci. 2023, 24, 8171.
https://doi.org/10.3390/ijms24098171
AMA Style
Carmona-Maurici J, Rosa A, Azcona-Granada N, Peña E, Ricart-Jané D, Viñas A, López-Tejero MD, Domingo JC, Miñarro A, Baena-Fustegueras JA,
et al. Irisin as a Novel Biomarker of Subclinical Atherosclerosis in Severe Obesity. International Journal of Molecular Sciences. 2023; 24(9):8171.
https://doi.org/10.3390/ijms24098171
Chicago/Turabian Style
Carmona-Maurici, Júlia, Araceli Rosa, Natalia Azcona-Granada, Elionora Peña, David Ricart-Jané, Anna Viñas, Maria Dolores López-Tejero, Joan Carles Domingo, Antonio Miñarro, Juan Antonio Baena-Fustegueras,
and et al. 2023. "Irisin as a Novel Biomarker of Subclinical Atherosclerosis in Severe Obesity" International Journal of Molecular Sciences 24, no. 9: 8171.
https://doi.org/10.3390/ijms24098171
APA Style
Carmona-Maurici, J., Rosa, A., Azcona-Granada, N., Peña, E., Ricart-Jané, D., Viñas, A., López-Tejero, M. D., Domingo, J. C., Miñarro, A., Baena-Fustegueras, J. A., Peinado-Onsurbe, J., & Pardina, E.
(2023). Irisin as a Novel Biomarker of Subclinical Atherosclerosis in Severe Obesity. International Journal of Molecular Sciences, 24(9), 8171.
https://doi.org/10.3390/ijms24098171